NGM Biopharmaceuticals, Inc.

Historical 13F Holders

Symbol
NGM
CUSIP
62921N105
All holders as of
Q1 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 82 35.0 M $55.7 M
2023 Q4 89 41.4 M $35.6 M
2023 Q3 102 48.3 M $51.7 M
2023 Q2 110 48.0 M $124 M
2023 Q1 129 48.9 M $201 M
2022 Q4 132 50.3 M $253 M
2022 Q3 138 53.2 M $695 M
2022 Q2 129 47.8 M $612 M
2022 Q1 119 48.5 M $739 M
2021 Q4 125 47.1 M $834 M
2021 Q3 132 45.2 M $951 M
2021 Q2 112 43.4 M $855 M
2021 Q1 113 43.0 M $1.25 B
2020 Q4 94 37.2 M $1.13 B
2020 Q3 84 34.2 M $544 M
2020 Q2 87 33.8 M $667 M
2020 Q1 75 32.6 M $403 M
2019 Q4 61 29.0 M $537 M
2019 Q3 53 26.4 M $365 M
2019 Q2 49 26.2 M $382 M